New gene linked to aggressive, treatment-resistant prostate cancer
“These findings highlight that, in PC, RSPO2 functions as a unique member of the R-spondin family by promoting genes and signaling pathways associated with aggressive PC, and RSPO2 amplifications are associated with poor outcomes in PC patients.”
2025-08-11
(Press-News.org)
“These findings highlight that, in PC, RSPO2 functions as a unique member of the R-spondin family by promoting genes and signaling pathways associated with aggressive PC, and RSPO2 amplifications are associated with poor outcomes in PC patients.”
BUFFALO, NY – August 11, 2025 – A new research paper was published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the functional differences and clinical features of R-spondin family members in metastatic prostate cancer.”
In this study, researchers led by first author Aiden Deacon and corresponding author Justin Hwang from the University of Minnesota-Twin Cities investigated a group of genes known as the R-spondin family (RSPO1/2/3/4) in advanced prostate cancer (PC). The RSPO gene family regulates Wnt signaling, a pathway involved in cancer progression.
Prostate cancer is the most common cancer among men in the United States and becomes especially dangerous when it spreads beyond the prostate. Most patients are treated with hormone therapies that target the androgen receptor; however, many tumors eventually become resistant.
The research team analyzed thousands of tumor samples and found that RSPO2 alterations were more common than changes in other R-spondin genes or even some well-known cancer-related genes like CTNNB1 and APC. RSPO2 amplification occurred in over 20% of metastatic prostate cancer. Patients with these alterations showed signs of more aggressive disease, including higher mutation rates and greater tumor complexity.
Using laboratory models, the team discovered that RSPO2 increases cancer cell growth and triggers a biological process called epithelial-mesenchymal transition (EMT). EMT is known to promote tumor spread and resistance to standard treatments. Unlike other genes in the same pathway, RSPO2 also appeared to reduce the activity of androgen receptor genes, suggesting it drives a type of prostate cancer that no longer relies on hormones for growth.
“In cell lines, RSPO2 overexpression caused up-regulation of EMT pathways, including EMT-regulatory transcription factors ZEB1, ZEB2, and TWIST1.”
Importantly, RSPO2 showed structural differences from other R-spondin proteins, which may allow researchers to design drugs that specifically block its activity. Current therapies targeting the Wnt pathway are limited, and there are no approved drugs that inhibit RSPO2. However, this study highlights RSPO2 as a promising therapeutic target, especially for patients who do not respond to existing hormone-based treatments.
This research adds critical knowledge about how aggressive prostate cancers develop and persist despite therapy. The identification of RSPO2 as a key driver of disease progression opens new possibilities for treatment strategies aimed at improving outcomes for patients with advanced prostate cancer.
Continue reading: DOI: https://doi.org/10.18632/oncotarget.28758
Correspondence to: Justin Hwang – jhwang@umn.edu
Keywords: cancer, RSPO2, prostate cancer, Wnt signaling, genomics, therapeutics
Click here to sign up for free Altmetric alerts about this article.
About Oncotarget:
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-08-11
Oxytocin promotes social behaviors and helps maintain relationships. But clinical trials in patients with autism show variability in how consistently oxytocin improves these behaviors. Steve Chang, from Yale University, led a study to explore how oxytocin influences brain activity to shape social behavior in rhesus monkeys and why its effects are so variable. This work is featured in JNeurosci’s Central Questions for Social Neuroscience Research Special Collection.
The researchers focused on the basolateral amygdala (BLA) and the anterior cingulate cortex (ACC) because these brain areas process reward and integrate ...
2025-08-11
The International Society for Stem Cell Research (ISSCR) released an update of its 2021 Guidelines for Stem Cell Research and Clinical Translation today. The targeted update addresses significant advances in the development and application of human stem cell-based embryo models (SCBEMs) and recommendations for research oversight outlined in a white paper from the ISSCR Embryo Models Working Group published in June.
SCBEMs are three-dimensional stem cell-derived structures that replicate key aspects of early embryonic development. ...
2025-08-11
Building upon the success of the first in utero brain surgery for Vein of Galen Malformation (VOGM) reported in 2023, new data published today in JAMA provides further evidence for the potential use of fetal embolization for this condition.
VOGM is the most common type of congenital blood vessel abnormality, in which the earliest arteries that develop in the brain connect directly with the dominant vein in the young brain, rather than nourishing the brain tissue. This causes a tremendous rush of high-pressure, high-flow blood into the veins, putting the fetus at high risk for mortality, heart failure, brain ...
2025-08-11
Using dollar stores for food purchases may be a common practice for Americans looking to free up funds for the rest of their grocery list, researchers from Tufts University School of Medicine, the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University, and the USDA-Economic Research Service report on August 11 in the Journal of the Academy of Nutrition and Dietetics.
Their multi-year analysis of where households buy their non-restaurant calories found that dollar store food purchases are rising. Although the food purchased is less healthy compared with other food outlets, families are balancing this ...
2025-08-11
Two new national Reproducibility Networks have been launched in Georgia and Ukraine with support from the TIER2 project – a step towards strengthening open, transparent, and high-quality research practices in Horizon Europe Widening participation countries.
The TIER2 Reproducibility Network (RN) Award supported the creation of three RNs in Horizon Europe Widening Participation countries. In 2023 and 2024, research consortia from Georgia, Ukraine, and Serbia were selected through two open award calls, recognising their strong engagement in advancing Open Science and reproducibility, research integrity, and collaboration.
The Georgian Reproducibility ...
2025-08-11
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London in partnership with the Mayo Clinic and UNEEG medical, has found that an electronic device placed under the scalp is an effective and feasible means of accurately tracking epilepsy.
In a landmark study, published in Epilepsia and funded by the Epilepsy Foundation of America, researchers demonstrated that seizures can be tracked in the home environment, giving clinicians access to data that could have a dramatic impact on the way in which epilepsy is treated in the future.
Tracking epileptic seizures over time is challenging ...
2025-08-11
To the point
Role of livestock in spreading the plague: Yersinia pestis has been identified in a 4,000-year-old sheep, indicating that livestock played a role in spreading an early form of plague that once circulated throughout Eurasia during the Late Neolithic and Bronze Age (LNBA) periods.
Spillover from unknown reservoir: Genetic analysis reveals that humans and sheep were infected by nearly identical plague strains. The disease was contracted through spillover from an unknown wild animal reservoir, and sheep ...
2025-08-11
About The Study: This study analyzes use of online asynchronous telemedicine abortion services for the period July 2023 through September 2024 via data from a nonprofit asynchronous telemedicine service that provides abortion medications throughout the U.S.
Corresponding Author: To contact the corresponding author, Abigail R. A. Aiken, PhD, email araa2@utexas.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.11420)
Editor’s Note: Please see the article for additional information, including other authors, author contributions ...
2025-08-11
About The Study: In this cohort study of individuals with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use was associated with a modestly increased risk of incident diabetic retinopathy (DR); however, fewer patients experienced sight-threatening DR complications, including blindness, even among those with preexisting DR. These findings suggest that all patients with T2D treated with GLP-1 RAs, regardless of preexisting DR, should be regularly screened and monitored for potential complications of T2D.
Corresponding Author: To contact the corresponding author, Sarju Ganatra, ...
2025-08-11
About The Study: In this study of patients with type 2 diabetes who had no prior eye disorders, patients prescribed semaglutide or tirzepatide had an increased risk of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders, although the overall risk was low. These findings highlight the need for close monitoring of these conditions.
Corresponding Author: To contact the corresponding author, Rong Xu, PhD, email rxx@case.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.26327)
Editor’s ...
LAST 30 PRESS RELEASES:
[Press-News.org] New gene linked to aggressive, treatment-resistant prostate cancer
“These findings highlight that, in PC, RSPO2 functions as a unique member of the R-spondin family by promoting genes and signaling pathways associated with aggressive PC, and RSPO2 amplifications are associated with poor outcomes in PC patients.”
